Staphylococcus aureus, inducible resistance, D-test
Background: Staphylococcus aureus is commensal flora but it can lead minor skin infections to life threatening conditions such as endocarditis, pneumonia and septicemia. Spread of multi drug resistance MRSA, therapeutic options become severely limited. Clindamycin can be an alternative option for use in the increasing drug resistance among the staphylococci. However, resistance to clindamycin can be missed in the laboratory, unless look specially thus necessitating the need to detect such resistance by a simple D test on routine basis.
Objectives: To find clindamycin resistance among clinical isolates of S aureus by disk-approximation test (D-test) and to establish methicillin resistant Staphylococcus aureus (MRSA) isolates and its relationship with inducible clindamycin resistance.
Materials and Methods: S. aureus isolated from various clinical specimens in microbiology unit BP Koirala Institute of Health Sciences hospital, Nepal from 8th March 2012 to 10th September 2012 was studied. Isolation and identification of organism was done by standard microbiological technique. S aureus resistant to erythromycin Kirby Baur disk diffusion test and phenotypic expression on inducible resistance was assessed using D-test.
Results: Among 300 S. aureus 41% were methicillin resistant. MRSA demonstrated 11.6% constitutive MLSBc. D test positive inducible resistance (MLSBi) found to be 24.59% and (22.4%) were MS type among MRSA isolates.
Conclusion: It was found 11.6% of isolates were inducible resistance to clindamycin, thus highlighting, whenever clindamycin is intended to be used for S. aureus infections, D-test should be performed to facilitate the appropriate treatment of patients.
Mandell G, enett JE, Dolin Raphael. Principles and Practice of Infectious Diseases. 4th ed. Staphylococcus aureus. New York: Churchil Living Stone 1990; 1756.
Smith TL, Pearson ML, Wilcox KL, Cruz C, Lancaster MV, Robinson-Dunn B, et al. Emergence of Vancomycin resistance in Staphylococcus aureus. Glycopeptide Intermediate Staphylococcus aureus Working Group. N Eng JMed 1999; 340: 493-501.
Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH. Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol 2003; 41: 4740-4.
Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 2002; 34: 482-92.
Deotale V, Mendiratta, Raut U, Narang P. Inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples. IJMM 2010; 28(2):124-6.
Kasten MJ. Clindamycin, metronidazole and chloramphenicol. Mayo Clinc Proc 1999; 74: 825-33.
Lewis JS 2nd, Jorgensen JH. Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned? Clin Infect Dis 2005; 40: 280-5.
Levin TP, Suh B, Axelrod P, Truant AL, Fekete T. Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure. Antimicrob Agents Chemother 2005; 49: 1222-4.
Drinkovic D, Fuller ER, Shore KP, Holland DJ, Ellis-Pegler R. Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance. J Antimicrob Chemother 2001; 48: 315-6.
Schreckenberger PC, Ilendo E, Ristow KL. Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and Coagulase negative staphylococci in a community and a tertiary care hospital. J Clin Microbiol 2004; 42: 2777-9.
Clinical and Laboratory standards institute. Performance standards of antimicrobial susceptibility testing; Ninth edition Vol. 26. No. 1 Clinical Laboratory Standards Institute; 2006.
Thapa S, Bahadur Sapkota LB. Prevalence of inducible clindamycin resistance in erythromycin resistant clinical isolates of Staphylococcus aureus and CONS at tertiary care hospital. JCMS Nepal. 2016; 12(3):83-8.
Kumar Singh KG, Chaudhari K B, Parajuli P K. Phenotypic study of Macrolide-Lincosamide-Streptogramin B Resistance in Staphylococcus aureus and their relationship with Methicillin-Resistant Staphylococcus aureus (MRSA) at Tertiary Care in Eastern Nepal. Journal of Nobel Medical College.2016; 5(1):1-4.
Prakash Sah P, Khanal R, Lamichhane P, Upadhaya S, Apsana Lamsal A, P and Kumar Pahwa K V. Inducible and constitutive clindamycin resistance in Staphylococcus aureus: an experience from Western Nepal. IJBR 2015; 6(05): 316-319. 316.
Vivek S J, Gandham N R, Sharma M, Kaur M, Misra R.N , Matnani G.B , Ujagare M, Saikat B, Kumar A. Prevalence of inducible Clindamycin resistance among community-and hospital-associated Staphylococcus aureus isolates in a tertiary care hospital in India. Biomedical Research 2011; 22 (4): 465-469.
Upadhya A, Biradar S. Prevalence of inducible clindamycin resistance in Staphylococcus aureus in a tertiary care hospital in north-east Karnataka, India. Prevalence of inducible clindamycin resistance in Staphylococcus aureus in a tertiary care hospital in north-east Karnataka, India. Health sciences: An International Journal 2011; 1(3): 21-24.
Sureerat Chelae S. Detection of Inducible Clindamycin Resistance in Staphylococci by Disk Diffusion Induction Test. J Med Assoc Thai 2009; 92 (7): 947-51.
Haznedaroglu T, Mehmet K, Baylan O, Mustafa O, Nurittin A. Testing for induction of clindamycin resistance in erythromycin-resistant isolates of coagulase negative staphylococci and Staphylococcus aureus. T?p Ara?t?rmalar? Dergisi: 2011: 9 (2):120 -127.
Fasih N, Irfan S, Zafar A, Khan E, Hasan R. Inducible clindamycin resistance due to expression of erm genes in Staphylococcus aureus: Report from a Tertiary Care Hospital Karachi, Pakistan. J Pak Med Assoc 2010; 60(9):750-754.
Copyright (c) 2017 International Journal of Biomedical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- An author must submit Copyright form After acceptance of the article.